ATP-sensitive potassium channel modulators and cardiac arrhythmias: an update

Area of Science:

• Cardiology
• Molecular Biology
• Pharmacology

Background:

• Cardiac arrhythmias, including atrial fibrillation and ventricular tachyarrhythmias, are significant causes of global morbidity and mortality.
• Current treatments have limitations, highlighting the need for improved pharmacological interventions, especially given the risks associated with implantable devices.

Purpose of the Study:

• To explore the dual role of cardiac ATP-sensitive potassium channels (KATP) in cardiac function and arrhythmia development.
• To evaluate the potential of KATP inhibitors as novel antiarrhythmic agents.

Main Methods:

• Review of research on the structure and function of sarcolemmal (sarcKATP) and mitochondrial (mitoKATP) channels.
• Analysis of the literature on KATP channel modulation in the context of cardiac stress and arrhythmias.

Main Results:

• KATP channels play a critical role in cellular functions and cardiac adaptive responses to metabolic stress.
• These channels exhibit a complex, paradoxical role in both promoting and protecting against atrial and ventricular arrhythmias.
• KATP inhibitors show potential as ischemia-selective antiarrhythmic drugs.

Conclusions:

• Modulation of KATP channels, specifically sarcKATP and mitoKATP, presents a promising strategy for developing new antiarrhythmic therapies.
• Development of cardioselective, chamber-specific, and combined sarcKATP/mitoKATP modulators is a key area for future drug discovery.